A multi-center pivotal field study to confirm the effectiveness and safety of verdinexor for the treatment of lymphoma in dogs
Ended Project Grant Awarded Last action
- Award ID
- R01FD006919
- Recipient
-
Anivive Lifesciences Inc. UEI HR9KVMTD5467
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $1,000,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding
-
- $750,000.00 Federal
- $250,000.00 Non-federal
- Funding agency
- Center for Veterinary Medicine Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Long Beach, CA 90807, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $250,000 | $0 | |
| Amendment | $250,000 | $250,000 | |
| Original award | $250,000 | $0 |
Quick answers
Who received award R01FD006919?
R01FD006919 was awarded to Anivive Lifesciences Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on June 1, 2020.
How much is award R01FD006919 worth?
$1,000,000 has been obligated on R01FD006919: $750,000 in federal funding and $250,000 in non-federal funding.
Which agency awarded R01FD006919?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded R01FD006919, with funding from Center for Veterinary Medicine (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award